Dennis Ridenour serves as the President & CEO of BioNexus KC, where he is dedicated to fostering a comprehensive life science and healthcare ecosystem. His work involves assisting life science and healthcare companies in bringing their technologies to market.
With over a decade of experience in scientific research, Ridenour has conducted research at institutions such as Harvard Medical School, Merck Research Labs, and the Stowers Institute for Medical Research.